RSV Prophylaxis Update

Due to current supply constraints for the new RSV prophylaxis agent Beyfortus (nirsevimab), the MO HealthNet Division (MHD) will allow up to five doses of Synagis (palivizumab) for the 2023 – 2024 RSV season. Participants who meet the clinical edit requirements, including age restrictions, may receive approval for up to five doses to start the 2023 - 2024 RSV season, depending on the requested date for the initial prior authorization.

Optimizing MO's Managed Care Plan Benefits for Maternal and Infant Health November 13, 2023

Please join the MO HealthNet Division (MHD) and meet our MHD Managed Care Health Plan representatives on November 13, 2023, at the Governor's Office Building in Jefferson City. This is a unique networking opportunity to showcase valuable benefits, incentives and resources available to perinatal patients and families including individualized Gestational Care Management for eligible patients.

Upcoming Relias Webinars

MO HealthNet | Relias 2023 Webinar Series

Free continuing education units are available for live and recorded sessions intended for physicians, nurses, and pharmacists. Click the registration links below for course objectives and continuing education information.

Maternal and Infant Health Engagement Survey for MO HealthNet Providers

The MO HealthNet Division (MHD) and the managed care health plans are collaborating on a project to educate and inform providers and participants/members on benefits and opportunities available to them during and after their pregnancy. Please take a quick five minute Maternal and Infant Health Engagement Survey to help us collect data to improve policies, payment methodologies and most importantly outcomes for pregnant and postpartum women and infants.